|1.||Alberti, Winfried: 6 articles (10/2005 - 03/2003)|
|2.||Davidson, Susan E: 5 articles (11/2010 - 11/2002)|
|3.||Hoeller, Ulrike: 5 articles (10/2010 - 03/2003)|
|4.||Gidday, Jeffrey M: 4 articles (04/2015 - 01/2012)|
|5.||Zhu, Yanli: 4 articles (04/2015 - 01/2012)|
|6.||Zhang, Lihong: 4 articles (04/2015 - 01/2012)|
|7.||Routledge, Jacqueline A: 4 articles (11/2010 - 06/2003)|
|8.||Burns, Meriel P: 4 articles (11/2010 - 06/2003)|
|9.||Rades, Dirk: 4 articles (10/2010 - 03/2003)|
|10.||Fehlauer, Fabian: 4 articles (10/2005 - 03/2003)|
|1.||Ganglion Cysts (Ganglion)
08/01/1989 - "However, mean ganglion cell soma diameter was significantly greater than normal in both the area centralis and temporal retina after neonatal enucleation. "
03/01/1990 - "Exposure to KA eliminated mainly small neurons of soma area 5-15 microns2, and medium-sized ganglion cells of soma area 15-25 microns2. "
03/01/2006 - "This study describes the different types of inward currents (Ii) recorded from the soma of isolated cochleovestibular ganglion (CVG) cells of the embryonic chicken, Gallus gallus. "
01/01/2006 - "A comparison of the data collected from the two cohorts of mice used for this study suggests that the initial site of damage in this disease is to the axons in the optic nerve, followed by the subsequent death of the ganglion cell soma."
08/01/2005 - "Studies of cultured adult pelvic ganglion neurons also demonstrated that NTN stimulated soma growth. "
04/01/2015 - "After 3 weeks of experimental glaucoma, the 21-27% reduction and 5-25% prolongation in flash visual-evoked potential amplitudes and latencies, respectively, and the 30% impairment in visual acuity were robustly improved in RH-Post-treated mice, as was the 17% loss in RGC soma number and 20% reduction in axon integrity. "
01/01/2013 - "The 90% and 81% improvement in soma and axon survival, respectively, observed in the wild-type mice treated with RHP (both p<0.05 versus the glaucoma eye in the untreated mice) was still observed to a near identical extent in the RHP-treated HIF-1α RGC-KO mice. "
01/01/2013 - "Although we also provided evidence that RHP prevents or delays the apoptotic demise of the RGC soma, the mechanisms responsible for signaling this epigenetic response, as well as the effectors of the glaucoma-tolerant phenotype at the somatic and axonal levels, remain unidentified. "
06/01/2012 - "Glaucoma caused an increase in RGC dendrite structure and soma size at 3 weeks."
06/01/2012 - "In combined glaucoma data, the RGC soma area was larger than control (P = 0.04, GEE model). "
|3.||Back Pain (Backache)
01/01/2010 - "The coprimary efficacy variables were patient-rated relief from starting backache and patient-rated global impression of change assessed on treatment day 3. The carisoprodol 250-mg regimen was significantly more effective than placebo as assessed by both patient-rated relief from starting backache (p = 0.0001) and patient-rated global impression of change (p = 0.0046). "
02/01/2008 - "Carisoprodol was significantly more effective than placebo for patient-rated global impression of change (2.24 vs. 1.70; p < 0.0001) and patient-rated relief from starting backache (1.83 vs. 1.12; p < 0.0001). "
01/01/2007 - "A 43-year-old woman with chronic back pain found relief by taking carisoprodol, a centrally acting skeletal muscle relaxant. "
02/01/2008 - "In this study, patients with acute muscle spasm of the lower back had significantly greater and more rapid relief from starting backache, and had improved functional status, as measured by the RMDQ, during treatment with carisoprodol 250-mg tablets compared to placebo. "
09/01/2004 - "Cochrane Library, MEDLINE, and EMBASE databases were searched (time frame: 1960 through January 2004; search terms: back pain, carisoprodol, cyclobenzaprine, metaxalone, muscle relaxants, and pharmacotherapy) and reference lists of identified articles were hand-searched. "
|4.||Body Weight (Weight, Body)
12/01/2008 - "Demonstration of the importance of this soma-brain reciprocal connection in body weight regulation in humans has been pursued using both classical genetic approaches and studies of physiological responses to experimental weight perturbation. "
01/01/2001 - "In the present study, we examined the length of the 2nd ceratobranchial cartilages (which unfold the dewlap), muscle fiber size, nerve cross-sectional area, and motoneuron soma size, as well as measures of body size (snout-vent length and body weight) at post-hatching days 1, 30, 60, 75, and 90. "
04/15/1994 - "Here we show that in juveniles the soma size of these neurons increases as a linear function of body weight. "
08/01/2000 - "In the carisoprodol in 0.5% methylcellulose study, males in the 200 mg/kg group and females in the 100 and 800 mg/kg groups had significantly greater mean body weights and body weight gains than did the vehicle controls. "
08/01/2000 - "The final mean body weight gain of males administered 1,600 mg/kg carisoprodol in corn oil was significantly less than that of the vehicle controls; the final mean body weights and body weight gains of female rats in the 800 and 1,600 mg/kg groups were significantly greater. "
01/01/2010 - "Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm."
06/01/2008 - "A 28-year-old woman with severe back muscle spasm took carisoprodol 2800 mg/day before and throughout an uncomplicated pregnancy and while exclusively breast-feeding her infant during the first month after birth. "
04/01/1993 - "Carisoprodol use should be limited to short-term treatment of acute musculoskeletal conditions involving significant muscle spasm. "
08/01/1965 - "USE OF CARISOPRODOL IN SYMPTOMATIC THERAPY OF PAINFUL MUSCLE SPASM."
11/01/2011 - "Carisoprodol is a centrally acting drug used to relieve skeletal muscle spasms and associated pain in acute musculoskeletal conditions. "
|3.||Corn Oil (Oil, Corn)
|4.||Caffeine (No Doz)
|10.||DNA (Deoxyribonucleic Acid)
|1.||Vasectomy (Vas Occlusion)
|4.||Fluid Therapy (Oral Rehydration Therapy)